Europe Microcarriers Market Revenue to cross US$ 1,035.52 million by 2030

At 12.0% CAGR, Europe Microcarriers Market is Speculated to be Worth US$ 1,035.52 Million by 2030, says Business Market Insights

According to Business Market Insights research, the Europe microcarriers market was valued at US$ 417.19 million in 2022 and is expected to reach US$ 1,035.52 million by 2030, registering a CAGR of 12.0% from 2022 to 2030. Need for cell therapies with rising incidence of cancer and infectious diseases and surge in adoption of regenerative medicine are among the critical factors attributed to the Europe microcarriers market expansion.

The rising adoption of regenerative medicine has emerged as a significant driver propelling the growth of the microcarriers market. Regenerative medicine focuses on repairing, replacing, or regenerating damaged tissues and organs, making it a promising field for addressing various medical conditions. Microcarriers play a pivotal role in the cultivation and expansion of cells, a fundamental aspect of regenerative medicine. In regenerative medicine, cells are cultured outside the body before being transplanted, and microcarriers provide a suitable environment for cell attachment, proliferation, and differentiation. They serve as a substrate for cell growth in bioreactors, facilitating the efficient production of large quantities of cells. This is particularly crucial for regenerative therapies, where a substantial number of viable and functional cells are needed. Moreover, microcarriers enhance the scalability and cost-effectiveness of cell processes, addressing key challenges in the translation of regenerative medicine from research to clinical applications. As the regenerative medicine field continues to advance, with an increasing focus on stem cell therapies and tissue engineering, the demand for microcarriers is expected to escalate, driving innovation and expansion within the microcarriers market.

On the contrary, high cost of biologics and cell-based therapies hampers the Europe microcarriers market.

Based on product, the Europe microcarriers market is bifurcated into microcarriers beads and media & reagents. The microcarriers beads segment held 67.2% share of Europe microcarriers market in 2022, amassing US$ 280.29 million. It is projected to garner US$ 708.79 million by 2030 to expand at 12.3% CAGR during 2022-2030.

In terms of equipment, the Europe microcarriers market is categorized into bioreactors, culture vessels, and others. The bioreactors segment held 65.6% share of Europe microcarriers market in 2022, amassing US$ 273.54 million. It is projected to garner US$ 692.29 million by 2030 to expand at 12.3% CAGR during 2022-2030.

Based on application, the Europe microcarriers market is segmented into biopharmaceutical production, cell and gene therapy, tissue engineering and regenerative medicine, and other. The biopharmaceutical production beads segment held 51.0% share of Europe microcarriers market in 2022, amassing US$ 212.84 million. It is projected to garner US$ 549.07 million by 2030 to expand at 12.6% CAGR during 2022-2030. Further, biopharmaceutical production segment is categorized into therapeutic protein production and vaccine production.

Based on end user, the Europe microcarriers market is segmented into pharmaceutical & biotechnology companies, contract research organizations & contract manufacturing organizations, and academic & research institutes. The pharmaceutical & biotechnology companies segment held 55.9% share of Europe microcarriers market in 2022, amassing US$ 233.36 million. It is projected to garner US$ 593.06 million by 2030 to expand at 12.4% CAGR during 2022-2030.

By country, the Europe microcarriers market has been categorized into Germany, the UK, France, Italy, Spain, and the Rest of Europe. Our regional analysis states that Germany captured 29.9% share of Europe microcarriers market in 2022. It was assessed at US$ 124.93 million in 2022 and is likely to hit US$ 323.34 million by 2030, exhibiting a CAGR of 12.6% during 2022-2030.

Key players operating in the Europe microcarriers market are Teijin Ltd, Bio-Rad Laboratories Inc, denovoMATRIX GmbH, Sartorius AG, Danaher Corp, Corning Inc, Eppendorf SE, Percell Biolytica AB, Asahi Kasei Corp, and Polysciences Inc, among others.